Abstract:A novel series of molecules combining imidazo[4,5‐c] pyridines, piperidines, and sulphonamide/carboxamide derivatives were synthesized and assessed for their anticancer potential against MCF‐7 and A549 cells, with cisplatin and Doxorubicin as the reference drugs. Compound 11 b exhibited remarkable inhibition, with an IC50 of 12.26 μM against A549 cells, while 11 d showed potent inhibition with an IC50 of 13.37 μM against MCF‐7 cells. Molecular docking studies against estrogen receptor alpha (ERα) indicates strong binding interactions and favourable energies compared to the co‐crystallized ligand 4‐hydroxytamoxifen. Additionally, pharmacokinetic evaluations suggest these molecules possess promising drug like qualities, making them potential therapeutic agents. Design and synthesis of a series of novel hybrid molecules that combine Imidazo[4,5‐c] pyridines with piperdines are presented in this paper. Total 17 derivatives were meticulously synthesized and characterized using 1H NMR, 13C NMR, MS and elemental analysis techniques. The in vitroanticancer activities are estimated by verifying their effectiveness against the MCF‐7 human breast adenocarcinoma and A549 lung cancer cell line, with cisplatin and doxorubicin serving as reference drugs. Several of these compounds demonstrated significant potential, displaying IC50 values within the range of 12.26–84.5 μM for A549, and 13.37–69.82 μM for MCF‐7. Notably, compound 11 bis found to be more potent than the standard drug cisplatin with an IC50 of 12.26±0.8 μM against A549 cells, while compound 11 d exhibited highest inhibition with an IC50 of 13.37±0.4 μM against MCF‐7 cells. Although its effectiveness was moderately lower when compared to doxorubicin, it still retained substantial anticancer activity. Molecular docking studies were performed to decouple the binding affinity and ligand interactions of the compounds with the estrogen receptor alpha (ERα) (PDB ID: 3ERT). The pharmacokinetic evaluation revealed favourable drug‐likeness properties for all the molecules, suggesting their potential as therapeutic agents.

Synthesis and Antitumor Activity of Tetrahydroimidazo[2′,1′:2,3]thiazolo [5,4-C]piperdine Derivatives

Synthesis and Evaluation of 2-[2-(phenylthiomethyl)-1h-benzo[d] Imidazol-1-yl)acetohydrazide Derivatives As Antitumor Agents

Synthesis, Crystal Structure and Evaluation of Cancer Inhibitory Activity of 4-[Indol-3-yl-methylene]-1h-pyrazol-5(4h)-one Derivatives

Synthesis and anti-tumor activity of 1-［bi-(4-fluoroph enyl)-methyl］-4-substituted piperazines Synthesis and anti-tumor activity of 1-［bi-(4-fluoroph enyl)-methyl］-4-substituted piperazines

SYNTHESIS AND ANTI-TUMOR ACTIVITIES OF 1,4 BIS[3- (AMINO-DITHIOCARBOXY)PROPIONYL] PIPERAZINE DERIVATIVES

Synthesis of novel piperazine-based bis(thiazole)(1,3,4-thiadiazole) hybrids as anti-cancer agents through caspase-dependent apoptosis

Synthesis and anticancer activities of 4-(4-substituted piperazin)-5,6,7-trialkoxy quinazoline derivatives

Design, Synthesis, and Antiproliferative Evaluation of Piperine Derivatives

Design,Synthesis and Anti-cervical Cancer Activity of Piperine-bicycloamide Derivatives

Design, synthesis, and evaluation of benzodioxolane compounds for antitumor activity

Synthesis and Cytotoxic Activity of Some Novel N-Pyridinyl-2-(6-phenylimidazo[2,1-b]thiazol-3-yl)acetamide Derivatives

Synthesis and antiproliferative evaluation of new hybrids of piperine and acylhydrazone

Synthesis Of Diaryl Ether Substituted Piperazine Derivatives And Their Cytotoxic Activities

Design, Synthesis and In‐Silico Studies of Piperidine‐Dihydropyridine Hybrids as Anticancer Agents

Design, Synthesis and Biological Evaluation of Novel 7-Amino-[1,2,4]triazolo[4,3-f]pteridinone, and 7-Aminotetrazolo[1,5-f]pteridinone Derivative As Potent Antitumor Agents

Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives containing benzodioxole as potential anticancer agents.

Synthesis and Anti-Tumor Activity of 1,4-Dihydrothieno[3',2':5,6]Thiopyrano[4,3-c]pyrazole-3-carboxylic Amide Derivatives

Design and Synthesis of Novel 5-Phenyl-n-piperidine Ethanone Containing 4,5-Dihydropyrazole Derivatives As Potential Antitumor Agents.

Synthesis and Cytotoxicity Screening of Piperazine-1-carbodithioate Derivatives of 2-Substituted Quinazolin-4(3H)-ones.

Synthesis, Biological Evaluation and Molecular Docking Study of Novel Benzhydryl Piperazine‐1,2,3‐Triazoline Hybrids

New Imidazo[4,5‐c]pyridine‐piperidine Hybrids as Potential Anti‐cancer Agents and In‐Silico Studies